Funding Keytruda for melanoma but not for lung cancer is racist, health advocates say

8 December 2021 - PHARMAC has been accused of institutional racism and breaching the Treaty of Waitangi for funding drugs ...

Read more →

Inclusion in health technology assessments: the first step toward equity

10 November 2021 - Many researchers working on health technology assessments are keen to address disparities in health care.  ...

Read more →

On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19

24 September 2021 - The World Health Organization welcomes the addition of another therapeutic to the world’s arsenal against COVID-19, ...

Read more →

Booster shots ‘make a mockery of vaccine equity,’ the WHO’s Africa director says

19 August 2021 - The Africa director at the World Health Organization, Dr. Matshidiso Moeti, criticized the decisions by some ...

Read more →

ICER to test principle of fair access to fairly priced pharmaceuticals

2 July 2021 - The controversial approval last month by the FDA of Aduhelm (aducanumab) for patients with early-stage Alzheimer’s disease ...

Read more →

Modifying NICE’s approach to equity weighting

7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...

Read more →

Vaccine distribution—equity left behind?

29 January 2021 - Over the past 2 weeks numerous US states have announced a major shift in coronavirus disease ...

Read more →

Big Pharma’s new CEOs must step up to erase inequities in drug access

16 December 2020 - I have been asked many times: Does the vision of the CEO have the power to ...

Read more →

PHARMAC funding resources to focus on medicines access equity

3 November 2020 - PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with ...

Read more →

Access to the latest and most effective diabetes drugs depends on where you live and what you earn

21 October 2020 - Access to the latest and most effective drugs for Australians with diabetes can depend on where ...

Read more →

COVID-19 vaccines: time to talk about the uncertainties

20 October 2020 - Plan now for decisions on which vaccines should go to whom, when and how often. ...

Read more →

Countries pledge nearly US$1 billion to support equitable access to COVID-19 vaccines

6 October 2020 - Gavi, the Vaccine Alliance has welcomed pledges made this week in support of the Gavi COVAX AMC, ...

Read more →

Rare Disorders New Zealand supports Human Rights Commission case against PHARMAC

17 September 2020 - Rare Disorders New Zealand supports patient advocate Fiona Tolich’s Human Rights Commission case against PHARMAC for ...

Read more →

A proposed lottery system to allocate scarce COVID-19 medications: promoting fairness and generating knowledge

28 July 2020 - On May 1, 2020, the US FDA issued an Emergency Use Authorization for the unapproved drug remdesivir ...

Read more →

PHARMAC report: should rich people get subsidised medicine?

29 July 2020 - Should wealthy New Zealanders have access to subsidised medicines when they could be investing in better ...

Read more →